Market: HKG |
Currency:
Address:
📈 2025 Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for 2025
No earnings history available for this symbol.
📰 Related News & Research
-
Lanteris Space Holdings LLC 2025-2024 Consolidated Financial Statements: Revenue, Impairment, and DOJ Investigation Overview
April 2, 2026
Key Financial Highlights and Developments: Lanteris Space Ho...
-
Interpace Biosciences Reports Strong 2025 Financial Results Driven by Thyroid Diagnostics Growth and One-Time Tax Benefit
April 2, 2026
Interpace Biosciences Reports Robust Q4 and Full Year 2025 R...
-
BSET 2025-2026 Financial Results: Sales, Expenses, and Segment Performance Analysis
April 2, 2026
Bassett Furniture Industries Q1 2026 Financial Results: Deta...
-
XWELL Reports 2025 Financial Results, Expands Wellness Services Beyond Airports and Strengthens Biosecurity Initiatives
April 2, 2026
XWELL, Inc. Reports Fiscal 2025 Results and Strategic Milest...
-
Prologis, Inc. Files Amended 8-K/A Report – Key Company and Security Information for September 18, 2025
April 2, 2026
Prologis, Inc. Files 8-K/A: Key Executive Change and Other D...
-
First America Resources Corp 2025 Annual Report – IT Asset Disposition, Electronics Recycling, and Technology-Driven Processing Overview
April 2, 2026
First America Resources Corp. 2025 Annual Report – Financial...
-
Sidus Space Inc: Innovative Satellite Manufacturing, AI-Enabled Space Solutions, and Growth Strategy in 2025
April 2, 2026
Sidus Space, Inc. 2025 Annual Report: Key Takeaways and Inve...
-
XWELL, Inc. 2025 Annual Report: Strategic Growth, Business Risks, and Financial Outlook
April 2, 2026
XWELL, Inc. 2025 Annual Report: Key Highlights and Sharehold...
-
Monopar Therapeutics Inc. 2025 Annual Report Amendment: Financial Highlights, Corrections, and Key SEC Filings
April 2, 2026
Monopar Therapeutics Inc. 10-K/A Detailed Report Summary ...
-
Artesian Resources Corporation 2025 10-K/A Annual Report – Company Information, Certifications, and XBRL Filings
April 2, 2026
Artesian Resources Corp. Files Amendment to 2025 Annual Repo...
🔍 View more Reports